Quipt Home Medical (TSE:QIPT) Given New C$7.50 Price Target at Stifel Nicolaus

Quipt Home Medical (TSE:QIPT) had its price target reduced by equities researchers at Stifel Nicolaus from C$8.40 to C$7.50 in a research note issued on Thursday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective would suggest a potential upside of 111.27% from the company’s current price.

Quipt Home Medical Price Performance

Shares of Quipt Home Medical stock traded up C$0.12 during trading on Thursday, hitting C$3.55. 15,500 shares of the company’s stock traded hands, compared to its average volume of 29,864. Quipt Home Medical has a twelve month low of C$3.28 and a twelve month high of C$6.98. The company has a market cap of C$152.97 million, a PE ratio of -20.88 and a beta of 1.01. The firm’s fifty day moving average price is C$3.72 and its 200 day moving average price is C$4.14.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.